Additionally in a case report, T-DM1 demonstrated its effectiveness in a heavily pretreated patient with recurrent USC overexpressing HER2/neu showing complete resolution of a large metastatic, radiation, and chemotherapy resistant tumor and a prolonged systemic control of disease [133]. The gene discussed is ERBB2; the disease is neoplasm.